文献速递耳科与耳神经小儿耳鼻咽喉

先天性巨细胞病毒靶向筛查的实施与结局:回顾性病历分析

Congenital Cytomegalovirus Targeted Screening Implementation and Outcomes: A Retrospective Chart Review.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-09-14

该回顾性病历分析评估了针对未通过新生儿听力筛查(NHS)婴儿实施靶向巨细胞病毒(CMV)检测方案的效果。2013至2020年间共回顾891份未通过NHS的婴儿病历,其中530例(60%)接受了CMV检测,8例(1.5%)阳性。全面实施靶向筛查后,CMV检测率从14%升至88%(P < .001),且初始感染科会诊的平均年龄显著更小(P < .001)。结论认为靶向筛查是早期识别CMV阳性婴儿的可行有效方法。

要点

  • 未通过NHS的婴儿中,靶向CMV筛查使检测率从14%提高至88%。
  • 891例未通过NHS婴儿中530例接受CMV检测,8例(1.5%)阳性。
  • 靶向筛查实施后,初始感染科会诊的平均年龄显著更小。

核心结论

  • 靶向筛查是早期识别CMV阳性婴儿的可行且有效方法。
  • 实施靶向筛查显著提高了未通过NHS儿童的CMV检测率并提早了感染科转诊。

研究设计与样本

  • 回顾性病历分析,纳入2013至2020年间未通过新生儿听力筛查的891名婴儿。
  • 2015年7月起在2级和3级新生儿病房引入靶向CMV筛查,2016年1月扩展至所有新生儿病房。

主要发现

  • 891份病历中530例(60%)接受了CMV检测,其中8例(1.5%)检测阳性。
  • 靶向筛查启动前检测出3例,启动后检测出5例。
  • 6例CMV阳性婴儿在确诊性听性脑干反应中显示听力损失,均开始口服缬更昔洛韦治疗;3例听力稳定,2例进展,1例改善。
  • 全面实施靶向筛查后,未通过NHS儿童的CMV检测率从14%增至88%(P < .001)。
  • 靶向筛查后出生的婴儿初始感染科会诊的平均年龄显著更小(P < .001)。

临床怎么用

  • 对未通过新生儿听力筛查的婴儿实施靶向CMV检测,可提高早期识别率并提早感染科转诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effectiveness and outcomes of a targeted cytomegalovirus (CMV) testing protocol. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary care institution. METHODS: Targeted screening for CMV in children who did not pass the newborn hearing screening (NHS) was introduced in July 2015 for the level 2 and 3 nurseries at our hospital. In January 2016, this policy was extended to include all nurseries. Retrospective chart review was performed for all newborns who did not pass their NHS between 2013 and 2020. CMV testing rates and related outcomes were compared before and after rollout. RESULTS: A total of 891 charts were reviewed for infants who did not pass their NHS: 530 (60%) had CMV testing, of which 8 (1.5%) tested positive. Three cases were detected prior to and 5 occurred after initiation of targeted screening. Six CMV+ infants demonstrated hearing loss on confirmatory auditory brainstem response, all of whom began treatment with oral valganciclovir. Hearing remained stable in 3 patients, progressed in 2, and improved in 1. The rate of CMV testing in children who did not pass their NHS increased from 14% to 88% after full implementation of targeted screening (P < .001). The average age at initial infectious disease consultation was significantly younger for infants born after targeted screening (P < .001). CONCLUSION: Targeted screening is a feasible and effective method to identify CMV+ infants early in life. Implementation of a targeted screening program for CMV in children who do not pass the NHS resulted in significantly higher rates of CMV testing and earlier referral to infectious disease.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Ronner EA, Glovsky CK, Herrmann BS, et al. Congenital Cytomegalovirus Targeted Screening Implementation and Outcomes: A Retrospective Chart Review. Otolaryngol Head Neck Surg. 2021. PMID: 34520270. doi:10.1177/01945998211044125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。